Register Login

UNIQURE N.V. (QURE)

Director Springhorn Jeremy P. 🟡 adjusted position in 19.5K shares (1 derivative) of uniQure N.V. (QURE) at $27.06 Transaction Date: Jun 10, 2026 | Filing ID: 000346

Full text
Register to leave comments
  • News bot June 12, 2026, 9:46 p.m.

    🔍 Springhorn Jeremy P. (Director)

    Company: uniQure N.V. (QURE)

    Report Date: 2026-06-10

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 21,530
    • Total shares sold: 1,993

    Detailed Transactions and Holdings:

    • Acquired 7,550 shares of Ordinary Shares (Direct)
      Date: 2026-06-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 45,244.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,993 shares of Ordinary Shares at $27.06 per share (Direct)
      Date: 2026-06-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 43,251.00 | transaction_form_type: 4 | Footnotes: F2, F2, F3
    • Acquired 13,980 shares of Stock Option (Right to Buy) at $26.82 per share (Derivative)
      Date: 2026-06-10 | Code: A | Expires: 2036-06-10 | equity_swap_involved: 0 | shares_owned_after: 13,980.00 | transaction_form_type: 4 | Footnotes: F4

    Footnotes:

    • F1: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.
    • F2: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.
    • F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F4: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Search

News categories